Fulgent Genetics, Inc. (FLGT): Operating Cash Flow
-$101.64M
Year ended 2025-12-31
-$83.70M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$101.64M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $21.06M | -22.0% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $27.00M | -89.3% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $253.52M | -52.9% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $538.58M | +283.0% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $140.63M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $5.52M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$675.0K | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $1.33M | -69.8% | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $4.41M | n/m | 2018-03-20, From 2016-01-01 |
| 2015-12-31 | -$969.0K | n/m | 2017-03-17, From 2015-01-01 |
| 2014-12-31 | -$4.40M | n/a | 2017-03-17, From 2014-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$101.64M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $24.59M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $64.35M | -0.8% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $42.03M | +10.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $136.31M | +81.5% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$299.01M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $83.16M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$184.76M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$23.27M | n/m |
Compare FLGT, BLLN, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗